Müller-Suur R, Eriksson S V, Strandberg L E, Mesko L
Department of Clinical Physiology, Hospital Physics and Internal Medicine, Danderyd Hospital, Stockholm, Sweden.
Cardiology. 2001;95(2):112-8. doi: 10.1159/000047356.
Beta-blocker therapy is used to decrease myocardial ischemia during exercise but may cause suboptimal diagnostic performance in exercise stress testing. The aim of the present study was to compare results of quantitative technetium-99-sestamibi single photon emission tomography (SPECT), following exercise stress test or pharmacological stress test with adenosine. We chose adenosine as comparison, since betablockers may not interfere with adenosine induced vasodilatation and therefore possibly may not interfere with its diagnostic performance. Sixteen patients with angiographically documented coronary disease (5 single-vessel, 6 two-vessel and 5 three-vessel disease), who were chronically treated with beta-blockers, performed SPECT imaging at rest, following bicycle exercise and following adenosine infusion in random order. The SPECT data were analyzed visually and quantitatively, using dedicated computer software (CEqual). According to both visual and quantitative SPECT analysis, adenosine was superior to show reversibility. Higher reversibility extent (50 +/- 15 vs. 26 +/- 12 pixels, p < 0.01) and more intense reversibility severity (110 +/- 29 vs. 49 +/- 23 sum of SDs, p < 0.05) were observed during adenosine than exercise.
Less myocardial perfusion abnormalities during exercise than during adenosine stress in patients treated with beta-blockers may indicate less ischemia but also an impaired diagnostic performance. Thus adenosine stress test should be preferred to optimize the diagnostic sensitivity in patients during beta-blocker treatment.
β受体阻滞剂疗法用于减轻运动期间的心肌缺血,但可能导致运动负荷试验的诊断性能欠佳。本研究的目的是比较运动负荷试验或腺苷药物负荷试验后,定量锝-99- sestamibi单光子发射断层扫描(SPECT)的结果。我们选择腺苷作为对照,因为β受体阻滞剂可能不会干扰腺苷诱导的血管舒张,因此可能不会干扰其诊断性能。16例经血管造影证实患有冠心病(5例单支血管病变、6例双支血管病变和5例三支血管病变)且长期接受β受体阻滞剂治疗的患者,以随机顺序在静息状态、自行车运动后以及腺苷输注后进行SPECT成像。使用专用计算机软件(CEqual)对SPECT数据进行视觉和定量分析。根据视觉和定量SPECT分析,腺苷在显示可逆性方面更具优势。与运动期间相比,腺苷期间观察到更高的可逆性范围(50±15对26±12像素,p<0.01)和更强的可逆性严重程度(标准差总和为110±29对49±23,p<0.05)。
在接受β受体阻滞剂治疗的患者中,运动期间的心肌灌注异常少于腺苷负荷期间,这可能表明缺血较少,但也提示诊断性能受损。因此,在β受体阻滞剂治疗期间,应首选腺苷负荷试验以优化诊断敏感性。